Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report) was up 1.9% during mid-day trading on Monday . Weiss Ratings restated a “sell (e+)” rating on shares of Enveric Biosciences in a report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Enveric Biosciences presently has a consensus rating of “Sell”. Enveric Biosciences (NASDAQ:ENVB – Get Free Report) last posted its quarterly earnings data on Friday, May 15th. Featured StoriesReceive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.